Paul L Crispen, M.D.

As a urologic oncologist I specialize in the surgical treatment of cancers involving the kidney, bladder, prostate, testis, and penis. My training as a Urologic Oncologist began at Temple University School Medicine where I received my medical degree and completed a Urology residency. Following completion of residency I received fellowship training in Urologic Oncology at the Mayo Clinic.

At University of Florida Health, I am an associate professor and specializes in the treatment of cancers involving the kidney, bladder, testis and penis. My clinical interests focus on the surgical management of renal and bladder cancer, including minimally invasive techniques. While my practice focuses on the surgical management of urologic malignancies I place great emphasis on multidisciplinary cancer care involving medical and radiation oncologists. Administratively, I am an active member of the UFHealth Cancer Center and the leader of the Genitourinary Disease Site Group and the Chairman of the Scientific Review and Monitoring Committee.

My research interest is primarily related to improving the evaluation and treatment of patients presenting with genitourinary malignancies. To date, most of my research effort has focused on the management of bladder and kidney cancer. Additionally, I have a strong interest in involving appropriately selected patients in clinical trials which are designed to evaluate new treatment regimens and hopefully improve the care of patients at the University of Florida and beyond.